Table 2.
Construct | Endocytosis ratea
|
Relative phosphate incorporationb
|
||||
---|---|---|---|---|---|---|
−PMA (%/min) | +PMA (%/min) | +PMA:−PMA | −PMA | +PMA | +PMA:−PMA | |
wtCD4 | 5 ± 0.9 | 19.2 ± 3.3 | 3.8 | 1 | 6.1 | 6.1 |
n = 11 | n = 8 | n = 7 | n = 7 | |||
K418 | 4.2 ± 0.9 | 18.2 ± 3.4 | 4.3 | 1.2 | 6.3 | 5.2 |
n = 3 | n = 3 | n = 7 | n = 7 | |||
R412 | 2.4 ± 0.2 | 2.3 ± 0.4 | 1 | 0.9 | 4.4 | 4.9 |
n = 3 | n = 3 | n = 1 | n = 1 | |||
H399 | 1.2 ± 0.4 | 1.0 ± 0.2 | 1 | NDc | ND | |
n = 10 | n = 8 | |||||
Mutations in K418 background | ||||||
K418 S408A/S415A | 1.7 ± 1.0 | 4.2 ± 0.2 | 2.4 | ND | ND | |
n = 3 | n = 4 | |||||
K418 S408E/S415E | 1.9 ± 0.8 | 4.1 ± 0.1 | 2.2 | ND | ND | |
n = 3 | n = 3 | |||||
K418 S408A | 1.7 ± 1.0 | 7.1 ± 1.7 | 4.1 | 0.7 | 4.0 | 5.7 |
n = 3 | n = 3 | n = 4 | n = 4 | |||
K418 S408E | 2.7 ± 0.5 | 13.7 ± 4.5 | 5 | 2.0 | 8.3 | 4.1 |
n = 7 | n = 7 | n = 3 | n = 3 | |||
K418 S415A | 2.1 ± 0.4 | 6.6 ± 1.2 | 3.1 | 0.1 | 2.4 | 24 |
n = 3 | n = 3 | n = 1 | n = 1 | |||
K418 S415E | 2.0 ± 0.3 | 5.0 ± 0.6 | 2.5 | 0.1 | 2.5 | 25 |
n = 3 | n = 2 | n = 2 | n = 2 | |||
K418 L413A/L414A | 2.2 ± 0.7 | 2.5 ± 0.4 | 1 | 1.1 | 7.1 | 6.5 |
n = 4 | n = 3 | n = 3 | n = 3 | |||
K418 L413V | 1.6 ± 0.4 | 1.9 ± 0.2 | 1 | 2.7 | 5.9 | 0.5 |
n = 2 | n = 3 | n = 2 | n = 1 | |||
K418 L413V/L414V | 1.9 ± 0.5 | 2.3 ± 0.4 | 1 | 1.7 | 7.3 | 4.4 |
n = 2 | n = 3 | n = 1 | n = 1 |
Endocytosis rates were normally calculated over the first 4 min after warmup except in PE-treated cells. Because the effects of PE were observed after a lag of ∼1 min (see Fig. 2A), the rates for these cells were calculated 1–4 min after warmup. The effects of PE on CD4 endocytosis are given as the ratio of the rates +PMA:−PMA.
Phosphate incorporation for each construct (− and +PMA) is compared with wt CD4 immunoprecipitated from untreated cells (see MATERIALS AND METHODS). Wild-type CD4 is set to 1. n, number of experimental data sets used in these calculations.
ND, not detected.